Literature DB >> 12016095

Beta-agonist intrinsic efficacy: measurement and clinical significance.

Nicola A Hanania1, Amir Sharafkhaneh, Roger Barber, Burton F Dickey.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12016095     DOI: 10.1164/rccm.2109060

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  27 in total

Review 1.  Beta-agonists and asthma: too much of a good thing?

Authors:  Stephanie A Shore; Jeffrey M Drazen
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

2.  Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma.

Authors:  Fekri Abroug; Fahmi Dachraoui; Lamia Ouanes-Besbes
Journal:  Intensive Care Med       Date:  2016-01-29       Impact factor: 17.440

Review 3.  Regulation of mast cells by beta-agonists.

Authors:  Peter Peachell
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

4.  Role of Airway Smooth Muscle in Inflammation Related to Asthma and COPD.

Authors:  Hiroaki Kume
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Agonist efficacy and receptor desensitization: from partial truths to a fuller picture.

Authors:  Steven J Charlton
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

Review 6.  β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.

Authors:  Maria Gabriella Matera; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

Review 7.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 8.  Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.

Authors:  Nicola A Hanania; Burton F Dickey; Richard A Bond
Journal:  Curr Opin Pulm Med       Date:  2010-01       Impact factor: 3.155

Review 9.  Benefit-risk assessment of long-acting beta2-agonists in asthma.

Authors:  Catherine M Jackson; Brian Lipworth
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Authors:  Andrea Rossi; Sonia Khirani; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.